[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Healthcare Market Research Reports & Industry Analysis

Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.

Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.

The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.

Publications found: 114,310
Sort by:

Shanghai Weicon Co Ltd in Eyewear (China)

US$ 150.00

... one of the leading domestic contact lens manufacturers in China, Shanghai Weicon Co will continue to focus on quality as the top priority in its development ... and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore ...

December 2013 2 pages

Thurella AG in Health and Wellness (Switzerland)

US$ 150.00

... rooted in eastern Switzerland, and is a leading Swiss pioneer in organic produce thanks to its well-known brand Biotta, which is sold in 40 countries. Thurella has a ... data. Why buy this report? Get a detailed picture of the Health and Wellness market; Pinpoint growth sectors and identify factors driving ...

December 2013 2 pages

Valio - Vache Bleue SA in Health and Wellness (Belgium)

US$ 150.00

As Valio – Vache Bleue SA enjoys strong brand acceptance in Belgium, the company is expected to further develop its range of products. As healthier eating patterns are expected to continue, as well as a rise in consumer demand for products responding to food intolerance, Valio – Vache Bleue SA should benefit ...

December 2013 2 pages

Coastal Contacts, Inc in Eyewear (Canada)

US$ 150.00

Coastal Contacts Inc, a global operator and the largest internet retailer of prescription eyewear in Canada, will enter 2013 with the objective ... set of briefings detailing the strategic direction taken by a company. Discover key contact details, the company background and their competitive positioning through ...

December 2013 2 pages

Vitagermine SA in Health and Wellness (France)

US$ 150.00

... as organic baby food is rare despite the rising demand from parents. Vitagermine SA will continue to innovate by launching new products. In 2012, the company ... and distribution data. Why buy this report? Get a detailed picture of the Health and Wellness market; Pinpoint growth sectors and identify factors ...

December 2013 2 pages

Acute Lymphocytic/Lymphoblastic Leukemia Therapeutics Market – (Pipeline Forecast & Market Forecast in G8 Countries) (2011 – 2020)

US$ 5,650.00

... lymphocytic/lymphoblastic leukemia may also occur in adults. The acute lymphocytic/lymphoblastic leukemia market is segmented into two types—childhood acute lymphocytic/lymphoblastic leukemia and adult acute lymphocytic/lymphoblastic leukemia. The acute lymphocytic/lymphoblastic leukemia therapeutics market ...

December 2013 157 pages

POM Wonderful LLC in Health and Wellness (Netherlands)

US$ 150.00

POM Wonderful remains a niche and successful product in the Netherlands. The main objective of the company is to further consolidate its position in the Dutch ... distribution data. Why buy this report? Get a detailed picture of the Health and Wellness market; Pinpoint growth sectors and identify factors ...

December 2013 2 pages

2013 Healthcare Benchmarks: Health Risk Assessments

US$ 117.00

... have questioned the use of HRAs to probe individuals about lifestyle risk factors such as divorce or financial loss, citing a potential privacy violation ... on their use of HRAs. Download the executive summary of 2013 Healthcare Benchmarks: Health Risk Assessments. This 60-page resource provides metrics and ...

November 2013 60 pages

Healthcare Trends & Forecasts in 2014: Performance Expectations for the Healthcare Industry

US$ 124.00

... 2013 has been nothing short of unpredictable. Healthcare Trends & Forecasts in 2014: Performance Expectations for the Healthcare Industry, HIN's ninth annual industry ... with his 'pyramid of success' to assess the industry landscape for healthcare providers. He covers the top-of-mind issues for physicians and ...

November 2013 40 pages

Booming IVF Market in India

US$ 1,000.00

... is increasing at an alarming rate. According to RNCOS’ report “Booming IVF Market in India”, the IVF market is poised to witness impressive CAGR of around 14% over ... region-wise i.e. their penetration across East/West/North/South India; their structure i.e. chain, independent and hospital-based; the number of ...

November 2013 50 pages

Physician Views: Bayer's M&A catalyst – is Xofigo a paradigm shifter for the prostate cancer market?

US$ 695.00

... radiopharmaceutical - see In Focus: Bayer's M&A catalyst – FirstWord speaks to Xofigo's lead investigator. Impressive Q3 sales, and confirmation that Bayer and Algeta ... gain a better understanding of the outlook for Xofigo, this week's Physician Views poll will ask US-based urologists and oncologists... Where ...

November 2013

Physician Views: Sanofi's successor to Lantus - are endocrinologists impressed?

US$ 695.00

... hypoglycaemia – currently known as Insulin U300 – is the most important product in Sanofi's late-stage R&D pipeline. With submission to regulators expected next year ... in selected European markets and Japan – there appears to be an opportunity for Sanofi to push home an advantage with U300, particularly by building on the entrenchment ...

November 2013

Healthcare Deal Multiples (Select Transaction) - Part l

US$ 500.00

... of current valuations prevalent in the industry. The report is an extensive analysis of various rounds of funding the companies in Healthcare sector have secured through various Private Equity Transactions. The report projects actual Deal Multiples derived from the statutory filings ...

November 2013 62 pages

Worksite Weight Loss Programs: A Market Analysis

US$ 995.00

... new study by Marketdata examines the $1.2 billion business of worksite-based weight loss programs. This niche segment is one of the few bright spots ... used, findings of various national studies examining employer weight loss programs, worksite competitions, the nature of providers (large commercial and ...

November 2013 147 pages

Production of Niacin in China

US$ 1,192.00

... , which is in great demand in the fast-growing feed industry. The production of niacin in China started in the 1960s with small output. After the 20th ... experienced large capacity expansion, pulling down their prices. Most niacin producers in China adopt 3-picoline, whose capacity has risen from 20,000t ...

November 2013 13 pages

Enanta- It is just the beginning of good news

US$ 90.00

... SVR12 data of SAPPHIRE-I –oral regimen (ENTA’s /ABT-450 boosted Abbvie’s ritonavir, ... data from the first of six Phase III HCV trial of ENTA/AbbVie's using its oral IFN free regimen. ... 1) and regulatory filing in 2nd half of 2014 we expect ENTA shares to appreciate further. We are positive on the PhIII study ...

November 2013 2 pages

Carman's Fine Foods Pty Ltd in Health and Wellness (Australia)

US$ 150.00

Carman’s Fine Foods Pty Ltd continues to seek opportunities to strengthen its position in NH high fibre breakfast cereals and granola/muesli bars by adding new variants to its Carman’s range, while also making more investment to provide marketing support for existing products sold ...

November 2013 2 pages

Dairygold Co-op Society Ltd in Health and Wellness (Ireland)

US$ 150.00

Dairygold Co-op Society Ltd’s presence in health and wellness is thanks to its Be Smoothies brand. Be Smoothies has maintained its value share even in the face of a more general move away from smoothies in the recession thanks to the ‘Love Irish’ marketing tactic, of which Dairygold is perfectly ...

November 2013 2 pages

Green & Blacks Ltd in Health and Wellness (United Kingdom)

US$ 150.00

Having been bought by global brand owner Kraft Foods in 2010, the company is expected to be more focused on becoming a mainstream brand during the forecast period, especially after the move to 100% fair trade. The company will continue to invest in extensive media campaigns as well as increasing its consumer ...

November 2013 2 pages

Hubbards Foods Ltd in Health and Wellness (New Zealand)

US$ 150.00

... company has identified innovation as a key avenue for growth and is expected to provide new and innovative products in regards to the reduced fat, reduced sugar and gluten-free categories of health and wellness breakfast cereals. Hubbards Foods is anticipated to remain as a key player within health ...

November 2013 2 pages

Kerry Group Plc in Health and Wellness (Ireland)

US$ 150.00

Kerry Group will continue to hedge its bets over the forecast period, by expanding its own assortment of health and wellness brands, whilst also manufacturing private label products for leading retailers in Ireland. In terms of its own brands, it will focus on expanding its portfolio to cover ...

November 2013 3 pages

National Foods Pty Ltd in Health and Wellness (Australia)

US$ 150.00

National Foods Pty Ltd was acquired from San Miguel Corp by Kirin Holdings Co Ltd in 2007. Since then, it has remained as a standalone business. However, the 2009 acquisition by Kirin Holdings Co Ltd of Lion Nathan Ltd brought changes as the Japanese brewer sought to consolidate its ...

November 2013 2 pages

Organix Brands Plc in Health and Wellness (United Kingdom)

US$ 150.00

Organix will continue to position itself as a dynamic new company breaking into the organic baby food category, pioneering the healthiest possible options ... and Wellness by Prime Positioning, Health and Wellness by Type. Data coverage: market sizes (historic and forecasts), company shares, brand shares and ...

November 2013 2 pages

Ban Choon Marketing Pte Ltd in Health and Wellness (Singapore)

US$ 150.00

Ban Choon Marketing (Pte) Ltd is expected to extend its product portfolio under organic products further, so it is not limited to food products but also ... reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and ...

November 2013 2 pages

Competitor Analysis: Janus Kinase (JAK) and spleen tyrosine kinase (syk) Inhibitors

US$ 529.00

... developments in the pipeline of inhibitors of the janus-associated kinase (JAK) and of spleen tyrosine kinase provides a competitor evaluation in the field of active ... ) are made up of a family of four cytoplasmic tyrosine kinases—JAK1, JAK2, JAK3, and TYK2—that play pivotal roles in the signaling pathways ...

November 2013 69 pages

India IVF Treatment Market Outlook 2018

US$ 600.00

... IUI, IVF, and ICSI (intra cytoplasmic sperm injection). India has become one of the favored destinations for infertility treatments such as IVF due to several ... health care system. “India IVF Treatment Market Outlook 2018” report by KuicK Research gives comprehensive insight on following aspects related to booming IVF treatment market in India: Market Overview IVF Treatment Market Potential Total Fertility ...

November 2013 54 pages

Global Hearing Aid Market Report: 2013 Edition

US$ 800.00

... , certain people have relative insensitivity to sound. Such situation is termed as hearing impairment. The increase in volume above the usual sound levels ... serious challenges in terms of social stigma and rise in price pressure. The report on global hearing aid market contains a comprehensive analysis of the ...

October 2013 69 pages

Global Rheumatoid Arthritis Market: Trends and Opportunities (2013-2018)

US$ 800.00

... Scope of the report The report titled “Global Rheumatoid Arthritis Market: Trends and Opportunities (2013-2018)” provides an in-depth analysis of global rheumatoid arthritis market with special focus on biologics drugs. It also accesses the key opportunities and underlying trends in the market and outlines the ...

October 2013 64 pages

Global Multiple Sclerosis Market: Trends & Opportunities (2013-18)

US$ 700.00

... report titled “Global Multiple Sclerosis Market: Trends & Opportunities (2013-18)“ provide an insight into the market dynamics and various trends and opportunities associated with the global multiple sclerosis market. The report ... contributor to the global multiple sclerosis market has been assessed. The report concludes with a brief discussion of major factors driving the global multiple sclerosis market and profiles major ...

October 2013 54 pages

Physician Views: As Tecfidera approaches a critical juncture in Europe, how are neurologist perceptions towards Biogen Idec's MS drug shaping up?

US$ 695.00

... opinion leader feedback. Similarly, there is evidence to support the view that anticipation among European neurologists is equally high. When ... Delayed launch for Biogen Idec's Tecfidera said to be causing 'quasi-hysteria' among European MS patients). With Tecfidera now approaching what appears to be a critical ...

October 2013

Global Age-Related Macular Degeneration (AMD) Market: Trends and Opportunities (2013-2018)

US$ 800.00

... Report The report titled “Global Age-Related Macular Degeneration (AMD) Market: Trends & Opportunities (2013-2018)” provides an in-depth analysis of the global age-related macular degeneration market with detailed analysis of various ... Age-related macular degeneration (AMD) is a condition affecting older people, and involves the loss of the person's central field of vision. Several forms of AMD exist such as early AMD ...

October 2013 70 pages

Physician Views: Revisiting Pfizer's Xeljanz – is the oral revolution gaining traction in rheumatoid arthritis?

US$ 695.00

... Xeljanz to gain approval in Europe (see ViewPoints: Key opinion leader casts doubt as to whether Pfizer's Xeljanz ... Xeljanz's ability to inhibit progression of structural disease. FirstWord polled US-based rheumatologists in May to ascertain how physicians were utilising Xeljanz and this week's Physician Views ...

October 2013

2013 Healthcare Benchmarks: Dual Eligibles Care Coordination

US$ 107.00

... adherence, patient satisfaction, pharma costs, and other key metrics; ROI from duals care management; Greatest care coordination successes achieved; and much more. 2013 Healthcare Benchmarks: Dual Eligibles Care Coordination also delivers advice from Dr. Timothy Schwab, the ...

October 2013 40 pages

2013 Healthcare Benchmarks: Accountable Care Organizations

US$ 127.00

... a greater number of ACOs in the wings than one year ago. 2013 Healthcare Benchmarks: Accountable Care Organizations documents the numerous ways in which ... ACOs — in the respondents' own words. Impact of ACO model on population health, healthcare spend and other indicators; Early successes from ACOs; and The ...

October 2013 65 pages

Hospitality 2013

US$ 2,800.00

October 2013 22 pages

Sports Medicine Market Report: 2013 Edition

US$ 800.00

... sports medicine market, the report also analyzes the global orthopedics market and global arthroscopic market. The report elicits the intricacies of market size, factors influencing market ... expense. The report also provides company profiles of the key players in the global sports medicine market along with a ...

October 2013 48 pages

Personalized Medicine and Companion Diagnostic Market Q3 2013- A Strategic Analysis of Industry Trends, Technologies, Participants, and Environment

US$ 3,400.00

... in the EU Cost-effectiveness and Business Value of Personalized Medicine Consumer genomics and POC market Therapeutics and Companion Diagnostics (e.g., BRAC Analysis, Oncotype Dx , KRAS Mutations ...

October 2013 206 pages

Coronary Stents Market in India 2013

US$ 950.00

... after order is placed. Netscribes’ latest market research report titled Coronary stents Market in India 2013 states that manufacturers of coronary stents are experiencing high demand for their ... form of a much needed regulatory mechanism and will benefit the coronary stents market as well.

October 2013 134 pages

Research Report on China Traditional Chinese Medicine (TCM) Decoction Pieces Industry, 2013-2017

US$ 1,300.00

TCM decoction pieces industry is one of 3 pillar industries of China TCM industry, and TCM decoction pieces are important raw materials of Chinese ... (TCM) decoction pieces producing enterprises Import and export status of China traditional Chinese medicine (TCM) decoction pieces The following enterprises ...

October 2013 30 pages

Cooperativa Agrícola y Lechera de la Union Ltda in Health and Wellness (Chile)

US$ 150.00

Cooperativa Agrícola y Lechera de La Unión Ltda (Colun) continues to innovate with the goal of gaining value share within health and wellness. In 2012, the company launched its digestive yoghurt called Vilib Digestion to compete directly with Activia from Soprole and Danone’s Activia. The ...

October 2013 2 pages

Barilla Alimentare SpA in Health and Wellness (Italy)

US$ 150.00

... well. Expanding its better for you portfolio is a key strategy at Barilla, especially as the link between health and... Euromonitor International Local Company Profiles are ... data. Why buy this report? Get a detailed picture of the Health and Wellness market; Pinpoint growth sectors and identify factors ...

October 2013 2 pages

China Medical Materials & Supplies Market Report

US$ 680.00

... … This report covers following sections. Market Size Based on Zeefer's China Market Size Formula, by the analysis on market size, industry sales ... the structure and concentration ratio of the current medical materials & supplies market in China by means of Bain's Market Structure Classification and Index ...

October 2013 51 pages

Market Access Collection

US$ 4,095.00

The collection includes the following reports: Market Access Canada Market Access in the EU5 – a comparative overview Value-based Key Account Management and the NHS – ensuring optimal performance under new rules Biosimilars in Emerging Markets

October 2013

Marketing Collection

US$ 6,495.00

The collection includes the following reports: Pharma and Gamification: motivating positive outcomes – a primer The Impact of Mobile Health on Patient-Centric ... real-world commercial benefit from closed-loop marketing Driving Brand Value in Emerging Markets - winning strategies and tactics Big Data ...

October 2013

Medical Affairs Collection

US$ 2,295.00

The collection includes the following reports: MSL-KOL Engagement: delivering value under new rules Ensuring Optimal Medical Affairs Performance: Delivering Measurable Value The Path to Product Inclusion in Clinical Guidelines: Strategies for Success ...

October 2013

Emerging Markets Collection

US$ 3,295.00

The collection includes the following reports: Inside China’s Pharma Sales Force – insights from the frontline Branded Generics: Strategies and Tactics for Winning in Latin America Biosimilars in Emerging Markets Driving Brand Value in Emerging Markets - winning strategies and tactics

October 2013

Salim Ivomas Pratama Tbk PT in Health and Wellness (Indonesia)

US$ 150.00

The company is expected to continue expanding its palm oil plantations, palm mills and invest in improving yields from its plantations. The company is also expected to expand its sugar cane plantation and sugar manufacturing facilities in line with its parent company’s bid to become, according to Kompas ...

October 2013 3 pages

Tangmas PT in Health and Wellness (Indonesia)

US$ 150.00

... Frutang Bulir (Frutang FF fruit-flavoured drinks with orange pulp) in 2011, Tangmas is expected to come up with more innovative HW beverages in the forecast period. ... data. Why buy this report? Get a detailed picture of the Health and Wellness market; Pinpoint growth sectors and identify factors driving ...

October 2013 3 pages

Regeneron - Eylea’s Growth Potential and Pipeline is Lucrative Enough!

US$ 140.00

... of Eylea (aflibercept, VEGF-Trap Eye, L, wet-AMD, Central Retinal Vein Occlusion – CRVO, partnered with Bayer for ex-US) in Diabetic Macular Edema (DME) and myopic choroidal neovascularization (mCNV) and promise of the late-stage pipeline esp. anti-PCSK9 mAb, Alirocumab (REGN727, PhIII, Hypercholesterolemia ...

October 2013 7 pages

Les Huileries de Oued Souss in Health and Wellness (Morocco)

US$ 150.00

... its product portfolio will continue to be the main strategic plan for Les Huileries de Oued Souss. As the company operates mainly in the slow-growing mature category of NH olive oil, Les Huileries de Oued Souss will seek to invest in other HW food categories and this move to healthier products was ...

October 2013 2 pages

Filters

Search

Categories

111,821
370
94
240
545
1,146
94

Publishers

179
1
123
116
2,357
101
25
102
98
2,527
195
23
40
8,299
68
563
682
34
29,954
248
501
3,036
1
1
2
3
16
257
537
361
106
1
1,357
60
1,696
8
8,921
1,966
4
3,674
1,550
19
1
321
4,852
2,744
66
1
3
3
36
202
2,355
246
53
50
45
46
29
29
143
56
42
83
9
20
29
5
11
3
16,308
3
277
11
3
292
22
4
39
1
2
6,125
14
1
183
49
359
30
34
4,348
13
1
44
2
7
10
9
12
18
21
168
52
8
3
18
16
7
1
18
1
41
58
649
1
4
6
1
9
1
3
5
1
1
1
90
2
4
4
1
82
15
1,158
1
3
1
17
227
128
16
4
397
3
74
2
6
5
10
1
3
118
33
336
203
47
474
7
45
1
25
13
138
2
4

Regions

58
56
56
48
35
35
31
30
29
29
29
26
26
25
23
22
22
22
21
16
15
14
6
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1,693
51
52
3
34
2
2
1,178
115
172
26
33
94
14
49
45
28
18
58
25
23
39
23
39
24
14
49
28
34
130
46
60
63
198
49
17
52
39
30
44
43
37
32
19
55
145
34
30
28
17
17
16
14
96
40
133
53
45
29
15
457
1,819
67
921
758
180
2,003
101,671

Price

Date

Pages

Offers

98
23
1
2,731
276
1
1